Sweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growth

SyntheticMR AB

25/08/2026 13:36

Overview
Sweden medical imaging firm's Q2 sales rose 13% yr/yr
Operating loss for Q2 narrowed to -6.5 mln SEK from -8.6 mln SEK
Company saw strong cNeuro growth and regulatory approvals in UK and Switzerland

Outlook
Company aims to achieve profitability through increased sales and disciplined cost management
SyntheticMR plans to strengthen sales in key markets and develop strategic partnerships
Company awaits further feedback from FDA on cMRI ARIA regulatory review in the US

Result Drivers
CNEURO GROWTH - Co said cNeuro sales rose 63% yr/yr, helping drive overall sales growth
ASIA SALES - Co said Asia performed strongly, with sales driven by OEM business and India
OEM WEAKNESS IN US/EU - Co said US and Europe sales declined due to weaker OEM business

Company press release: ID:nWkr3pyzjX

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
 
SEK 14 mln
SEK 16 mln (1 Analyst)
Q2 Net Loss
 
SEK 6.1 mln
 
Q2 Operating Profit
 
-SEK 6.5 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Syntheticmr publ AB is SEK1.16, about 72.1% above its August 24 closing price of SEK0.67

Reuters Recommended Reads
Aug 25 - Sweden's Isofol Medical reports no Q2 revenue, net loss widens
Aug 24 - China's Shanghai INT Medical Instruments H1 revenue jumps on acquisitions
Aug 24 - China's Peijia Medical H1 revenue jumps on transcatheter valve therapeutics growth

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)